CCT5 and neoplasm: Compared to the corresponding normal tissues, the promoter methylation level of CCT5 in tumor tissues was significantly reduced, and the outcome was a reduction in the stability of transcriptional repression, consequently resulting in an elevation of CCT5 expression levels and promotion of tumor progression.